These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10701404)

  • 21. FDA notifications. Revised guidelines for pregnant women.
    AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
    [No Abstract]   [Full Text] [Related]  

  • 22. Side effects. Effect of combination therapy on pregnancy--results from Europe.
    TreatmentUpdate; 2001; 12(9):5. PubMed ID: 12132447
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of antiretroviral agents in the management of HIV infected people in Africa; scientific aspects of man and society. Recommendations of the Workshop of Gorée 2001].
    Bull Soc Pathol Exot; 2002 Mar; 95(1):53-7. PubMed ID: 12012967
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of vertical HIV-1 transmission.
    Skinner J; Turner MJ
    Lancet; 1999 Jun; 353(9171):2240. PubMed ID: 10393004
    [No Abstract]   [Full Text] [Related]  

  • 25. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIVNET 012 and Petra.
    Hudson CP
    Lancet; 2004 Jan; 363(9404):243; author reply 244. PubMed ID: 14738804
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of vertical HIV-1 transmission.
    Anderson JR; Hanna G; Gurewitsch E
    Lancet; 1999 Jun; 353(9171):2240-1. PubMed ID: 10393005
    [No Abstract]   [Full Text] [Related]  

  • 28. [Guidelines for the management of patients with HIV infection. II. Pregnant women and children. Liege Working Group on HIV Infection].
    Schmitz V; Nkoghe D; Hoyoux C; Dresse MF
    Rev Med Liege; 2000 May; 55(5):424-9. PubMed ID: 10941308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)].
    Moreno S; Arrizabalaga J; Gatell JM; Clotet B; Aguirrebengoa K; Antela A; Iribarren JA; Laguna F; Miró JM; Ocaña I; Rubio R; Viciana P; Podzamczer D
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):374-6. PubMed ID: 9835154
    [No Abstract]   [Full Text] [Related]  

  • 30. Mode of delivery and the risk of vertical transmission of HIV-1.
    Landers DV; Duarte G
    N Engl J Med; 1999 Jul; 341(3):205; author reply 206-7. PubMed ID: 10409036
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV in pregnancy: an update of current recommendations.
    Wilcox RD
    HIV Clin; 2003; 15(1):8-9. PubMed ID: 12569884
    [No Abstract]   [Full Text] [Related]  

  • 32. Mode of delivery and the risk of vertical transmission of HIV-1.
    Gelber RD; Shapiro DE
    N Engl J Med; 1999 Jul; 341(3):206-7. PubMed ID: 10409038
    [No Abstract]   [Full Text] [Related]  

  • 33. Life-threatening maternal and fetal macrocytic anemia from antiretroviral therapy.
    Myers SA; Torrente S; Hinthorn D; Clark PL
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1189-91. PubMed ID: 16260567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maternal factors and prevention of vertical HIV transmission].
    Bates Egam I
    Allergol Immunopathol (Madr); 1998; 26(3):120-2. PubMed ID: 9675393
    [No Abstract]   [Full Text] [Related]  

  • 35. More progress on preventing HIV infection in infants. Three trials this year pointed to the benefits of extending maternal antiretroviral prophylaxis throughout the breast-feeding period.
    Chimienti SN
    J Watch AIDS Clin Care; 2010 Jan; 22(1):6-7. PubMed ID: 20626070
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of postpartum HIV treatment discontinuation on long-term maternal outcome.
    Onen NF; Nurutdinova D; Sungkanuparph S; Gase D; Mondy K; Overton ET
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(5):245-51. PubMed ID: 18812593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral Pharmacokinetics in Pregnant Women.
    Gilbert EM; Darin KM; Scarsi KK; McLaughlin MM
    Pharmacotherapy; 2015 Sep; 35(9):838-55. PubMed ID: 26297552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Decision guides for antiretroviral treatment in pregnancy].
    Malinverni R; Rudin C
    Ther Umsch; 1998 May; 55(5):323-8. PubMed ID: 9643130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.